IFBD (IFBD) Stock Price & Analysis
IFBD (IFBD) rose 7.69% to USD 1.12 as of June 10, 2026 at 01:56 UTC, according to Nexqual real-time market data.
IFBD last closed at USD 1.04; the session ranged USD 1.02–1.47 on volume of 636,502 shares. Market capitalization is $9.17M, with a 52-week range of USD 0.66–2.18 (NCM). Source: Nexqual, June 10, 2026 at 01:56 UTC.
Key Statistics (as of June 10, 2026 at 01:56 UTC)
| Price | USD 1.12 |
|---|---|
| Change | ▲ 7.69% (up) |
| Previous Close | USD 1.04 |
| Open | USD 1.09 |
| Day Range | USD 1.02 – 1.47 |
| 52-Week Range | USD 0.66 – 2.18 |
| Volume | 636,502 shares |
| Market Cap | $9.17M |
| Exchange | NCM |
Technical Analysis (IFBD)
Nexqual's technical model rates IFBD "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 01:56 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 64 (neutral) |
| vs SMA50 | Above (USD 0.96) |
| MACD | 0.01 (positive) |
Analyst Ratings (IFBD)
Wall Street analysts rate IFBD "None", per Nexqual as of June 10, 2026 at 01:56 UTC.
| Consensus Rating | None |
|---|
Earnings (IFBD)
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Financials & Fundamentals (IFBD)
| Total Revenue | $8.71M |
|---|---|
| Revenue Growth (YoY) | +271.20% |
| Gross Margin | +29.50% |
| Operating Margin | -10.50% |
| Profit Margin | +0.00% |
| ROE | -134.59% |
| Debt / Equity | 5.64 |
| Current Ratio | 1.98 |
| Total Cash | $5.11M |
| Total Debt | $1.03M |
| Free Cash Flow | $265,452 |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Financial Health Score (IFBD)
Nexqual rates IFBD's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 01:56 UTC.
| Growth | Strong — Revenue +271% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $5M cash vs $1M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$522K |
| Efficiency | Critical — ROE -135%, ROA -2.1% |
Ownership (IFBD)
| Insider Ownership | +0.02% |
|---|---|
| Institutional Ownership | +0.31% |
| Shares Outstanding | 8.19M |
| Float | 8.19M |
| Short % of Float | +2.12% |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Leadership (IFBD)
IFBD is led by Xiangyang Wen (age 38), Chairman, President & CEO, per Nexqual as of June 10, 2026 at 01:56 UTC.
| Chairman, President & CEO | Xiangyang Wen (age 38) |
|---|---|
| CFO & Director | Yiting Song (age 38) |
Major Backers & Investors (IFBD)
Notable institutional backers of IFBD include Susquehanna International Group, LLP, according to Nexqual as of June 10, 2026 at 01:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Susquehanna International Group, LLP | 0.3% |
Source: Nexqual, June 10, 2026 at 01:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AUUD | Auddia Inc. | USD 1.3 | ▼ 0.76% |
| CPOP | Pop Culture Group Co., Ltd | USD 0.36 | ▲ 34.83% |
| SNTG | Sentage Holdings Inc. | USD 2.21 | ▼ 7.14% |
| BAOS | Baosheng Media Group Holdings L | USD 2.88 | ▲ 12.5% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.17 | ▼ 12.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 01:56 UTC. This page is informational and not investment advice.